Bruce Tallion

Title: Bruce Tallion: Innovator in Cytokine Research

Introduction

Bruce Tallion is a notable inventor based in Middletown, CT (US). He has made significant contributions to the field of biotechnology, particularly in the development of novel polypeptides and their applications in medical science. His work has implications for the detection and treatment of various pathological states.

Latest Patents

Tallion holds a patent for a WNT-regulated cytokine-like polypeptide and nucleic acids encoding the same. This invention provides novel polypeptides, termed FCTRX polypeptides, as well as polynucleotides encoding these polypeptides. Additionally, it includes antibodies that specifically bind to an FCTRX or its derivatives, variants, mutants, or fragments. The invention also outlines methods for using the FCTRX polypeptide, polynucleotide, and antibody in the detection and treatment of a broad range of pathological states.

Career Highlights

Throughout his career, Bruce Tallion has worked with prominent companies in the biotechnology sector, including Curagen Corporation and Genentech, Inc. His experience in these organizations has allowed him to contribute to significant advancements in the field.

Collaborations

Tallion has collaborated with notable colleagues, including David P Andrew and David A Lewin. These partnerships have further enriched his research and development efforts.

Conclusion

Bruce Tallion's innovative work in cytokine research and his patent for FCTRX polypeptides highlight his contributions to biotechnology. His career reflects a commitment to advancing medical science through innovative inventions.